Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship
about
Phytochemicals for the Management of MelanomaChemistry of silybin.Protective effects of silibinin and its possible mechanism of action in mice exposed to chronic unpredictable mild stressSilibinin and its 2,3-dehydro-derivative inhibit basal cell carcinoma growth via suppression of mitogenic signaling and transcription factors activation.Recent trends in preclinical drug-drug interaction studies of flavonoids--Review of case studies, issues and perspectives.5- or/and 20-O-alkyl-2,3-dehydrosilybins: Synthesis and biological profiles on prostate cancer cell models.Effect of silibinin-loaded nano-niosomal coated with trimethyl chitosan on miRNAs expression in 2D and 3D models of T47D breast cancer cell line.New Aspects of Silibinin Stereoisomers and their 3-O-galloyl Derivatives on Cytotoxicity and Ceramide Metabolism in Hep G2 hepatocarcinoma Cell Line.3-O-Alkyl-2,3-dehydrosilibinins: Two synthetic approaches and in vitro effects toward prostate cancer cells.Silibinin derivatives as anti-prostate cancer agents: Synthesis and cell-based evaluations.Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells.Hepatitis C virus dynamics and cellular gene expression in uPA-SCID chimeric mice with humanized livers during intravenous silibinin monotherapy.Natural autophagy regulators in cancer therapy: a reviewEffects of Silymarin-Loaded Nanoparticles on HT-29 Human Colon Cancer Cells
P2860
Q26766708-BF23B764-BD03-4528-AF17-9E2F9B3E189AQ30834026-14CC25B0-9B86-4952-93B9-F9051EBDE798Q35597505-4BA28744-A172-4351-B6A6-A2C2B3DC9A59Q35707004-9ABAD7A8-E3A3-4062-ABCA-E8D1E2E0100AQ38581733-685B0F20-FD92-499D-8277-A6997B0F29D4Q38653651-86B46093-62CF-4234-AD4C-9BE88E658818Q38703364-289F0D87-9257-4C81-8B64-76A35BB210FCQ38726003-6BE17459-21C9-4391-9153-B90F4D6CFD40Q38766644-AFDC6BBA-F6AB-4360-9DA6-EBDF7380FD1FQ38805238-5FDDC580-1B07-41ED-86E1-D2328DAF4BB3Q39063063-8721D554-D63F-4ED2-8483-DA6238950E4AQ40641829-46FD1A32-1918-425D-A44D-75ECCE187D1BQ57552247-448418EF-034D-48E4-A293-C37D78050168Q57826028-DF2F9415-210B-4317-9D44-BF7087A1037F
P2860
Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship
@ast
Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship
@en
Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship
@nl
type
label
Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship
@ast
Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship
@en
Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship
@nl
prefLabel
Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship
@ast
Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship
@en
Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship
@nl
P2093
P2860
P1433
P1476
Anti-cancer efficacy of silybin derivatives -- a structure-activity relationship
@en
P2093
Chapla Agarwal
David Biedermann
Gagan Deep
Radek Gažák
Rajesh Agarwal
Ritambhara Wadhwa
Vladimír Křen
P2860
P304
P356
10.1371/JOURNAL.PONE.0060074
P407
P577
2013-01-01T00:00:00Z